• Guideline Summary
  • NGC:010672
  • 1996 (revised 2014)

ACR Appropriateness Criteria® non-spine bone metastases.

  • Guideline Summary
  • NGC:009736
  • 2007 Jun (revised 2013 Apr)

NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.

  • Guideline Summary
  • NGC:009311
  • 2012 Aug

Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer.

  • Guideline Summary
  • NGC:010541
  • 2013 Aug

Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer.

  • Guideline Summary
  • NGC:009378
  • 2012 Jul

Staging investigations for asymptomatic and newly diagnosed breast cancer.

  • Guideline Summary
  • NGC:010700
  • 2014 Sep 30

Optimal systemic therapy for early female breast cancer.

  • Guideline Summary
  • NGC:009074
  • 2012 Apr

Eribulin for the treatment of locally advanced or metastatic breast cancer.

  • Guideline Summary
  • NGC:011064
  • 2016 Jun 8

Clinical utility of multigene profiling assays in invasive early-stage breast cancer.

  • Guideline Summary
  • NGC:010045
  • 2007 May (revised 2013 Sep)

Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.

  • Guideline Summary
  • NGC:011028
  • 2016

ACR Appropriateness Criteria® breast cancer screening.

  • Guideline Summary
  • NGC:010353
  • 2005 Oct 20 (revised 2014 May 1)

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. [Update Pending]

  • Guideline Summary
  • NGC:008706
  • 2010 Oct (republished 2012 Jan)

Magnetic resonance imaging for breast cancer screening, pre-operative assessment, and follow-up.